MeSH term
Frequency | Condition_Probility | Cells, Cultured | 15 | 0.0 |
Chemotaxis, Leukocyte/immunology | 2 | 3.0 |
Comparative Study | 8 | 0.0 |
Humans | 69 | 0.0 |
Immune Tolerance/*immunology | 2 | 4.0 |
Ligands | 5 | 0.0 |
Research Support, Non-U.S. Gov't | 40 | 0.0 |
Animals | 25 | 0.0 |
Chemokines, CC/*pharmacology | 2 | 9.0 |
Chemotactic Factors/pharmacology | 2 | 6.0 |
In Vitro | 3 | 0.0 |
Kinetics | 3 | 0.0 |
Mice | 18 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 22 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 9 | 0.0 |
Antigens, CD/analysis | 2 | 0.0 |
Chemokines/*metabolism | 3 | 5.0 |
Immunoenzyme Techniques | 2 | 0.0 |
Macrophage Inflammatory Protein-1/metabolism | 2 | 3.0 |
RANTES/metabolism | 2 | 3.0 |
Chemokines/*physiology | 2 | 6.0 |
Female | 15 | 0.0 |
Immunohistochemistry | 3 | 0.0 |
Tumor Cells, Cultured | 5 | 0.0 |
*Genome, Human | 2 | 0.0 |
Models, Genetic | 2 | 0.0 |
Killer Cells, Natural/*immunology | 2 | 0.0 |
Cell Line | 8 | 0.0 |
Cell Movement/physiology | 2 | 0.0 |
Models, Biological | 2 | 0.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
Adult | 8 | 0.0 |
Aged | 2 | 0.0 |
*Gene Expression Regulation | 3 | 0.0 |
Male | 12 | 0.0 |
Middle Aged | 7 | 0.0 |
Polymorphism, Genetic/genetics | 2 | 0.0 |
Receptors, CCR5/*genetics | 3 | 1.0 |
Cell Division | 2 | 0.0 |
Chemotaxis | 2 | 1.0 |
NF-kappa B/metabolism | 2 | 0.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Signal Transduction | 4 | 0.0 |
Cytokines/metabolism | 2 | 0.0 |
Up-Regulation | 5 | 0.0 |
Binding, Competitive | 2 | 0.0 |
CHO Cells | 2 | 0.0 |
HIV-1/*metabolism | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Structure-Activity Relationship | 3 | 0.0 |
Cell Line, Tumor | 3 | 0.0 |
Enzyme Activation | 2 | 0.0 |
Rats | 2 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
Monocytes/metabolism | 3 | 0.0 |
Polymerase Chain Reaction/methods | 2 | 0.0 |
Synovial Membrane/metabolism | 2 | 7.0 |
Analysis of Variance | 2 | 0.0 |
Blotting, Western | 2 | 0.0 |
DNA Primers | 2 | 0.0 |
Mice, Inbred C57BL | 4 | 0.0 |
Amino Acid Sequence | 5 | 0.0 |
Calcium Signaling/drug effects | 2 | 4.0 |
Chemotaxis/drug effects | 2 | 2.0 |
Down-Regulation/drug effects | 3 | 1.0 |
Molecular Sequence Data | 5 | 0.0 |
Protein Binding | 3 | 0.0 |
Receptors, Chemokine/*metabolism | 2 | 1.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Apoptosis/*physiology | 2 | 0.0 |
Arthritis, Rheumatoid/*immunology | 2 | 0.0 |
Cell Differentiation/immunology | 3 | 0.0 |
RNA, Messenger/analysis/biosynthesis | 2 | 0.0 |
Th1 Cells/immunology/metabolism | 2 | 5.0 |
Dose-Response Relationship, Immunologic | 2 | 0.0 |
Immunophenotyping | 2 | 0.0 |
Interleukin-1/biosynthesis | 2 | 1.0 |
Interleukin-6/biosynthesis | 2 | 0.0 |
Calcium/metabolism | 4 | 0.0 |
Flow Cytometry | 5 | 0.0 |
Pertussis Toxin/pharmacology | 2 | 3.0 |
Phosphorylation | 2 | 0.0 |
Time Factors | 3 | 0.0 |
Mitogen-Activated Protein Kinase 1/metabolism | 2 | 0.0 |
Treatment Outcome | 2 | 0.0 |
CD4 Lymphocyte Count | 3 | 0.0 |
Glucocorticoids/pharmacology | 2 | 1.0 |
Interleukin-10/pharmacology | 2 | 2.0 |
Lipopolysaccharides/pharmacology | 3 | 0.0 |
Macrophages/immunology | 2 | 0.0 |
Monocytes/immunology | 2 | 0.0 |
Cytokines/*biosynthesis | 2 | 0.0 |
Chemokines/*biosynthesis | 2 | 6.0 |
RNA, Messenger/biosynthesis | 4 | 0.0 |
Immunity, Natural | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Th2 Cells/immunology | 2 | 1.0 |
Lymphocyte Activation | 4 | 0.0 |
Mice, Knockout | 3 | 0.0 |
Macrophages/immunology/metabolism | 2 | 4.0 |
Mice, Transgenic | 2 | 0.0 |
Monocytes/immunology/metabolism | 2 | 4.0 |
Chemokines, CC/metabolism | 2 | 4.0 |
Gene Frequency | 4 | 0.0 |
Intercellular Signaling Peptides and Proteins/biosynthesis | 2 | 8.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
Chemokines/metabolism | 2 | 2.0 |
Enzyme-Linked Immunosorbent Assay | 3 | 0.0 |
HIV Seropositivity/immunology | 2 | 2.0 |
Genotype | 3 | 0.0 |
HIV-1/immunology | 2 | 2.0 |
RNA, Messenger/analysis | 3 | 0.0 |
Receptors, Chemokine/*genetics | 2 | 2.0 |
Anti-HIV Agents/*pharmacology | 2 | 1.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Transfection | 2 | 0.0 |
Case-Control Studies | 2 | 0.0 |
Immune Tolerance | 2 | 0.0 |
Cell Movement | 2 | 0.0 |
Base Sequence | 2 | 0.0 |
Chemokines, CC/biosynthesis/*genetics | 2 | 33.0 |
*Gene Expression Profiling | 2 | 0.0 |
Mast Cells/*metabolism | 2 | 5.0 |
Coculture Techniques | 3 | 0.0 |